From the newly announced U.S.-UK trade deal to shifting dynamics in the U.S.-China relationship, we explore the market’s reaction to recent announcements, including Trump’s proposed executive order targeting pharmaceutical pricing. Is the administration’s tariff strategy finally paying off? And what could lower drug prices mean for American consumers? Here is David’s take.